Etoricoxib Stada Contraindications

Etoricoxib STADA is contraindicated: In patients with severe heart failure.
For the treatment of peri-operative pain in the setting of coronary artery bypass graft surgery.
Hypersensitivity to the active substance or to any of the excipients listed in Description.
Active peptic ulceration or active gastrointestinal bleeding.
Patients who, after taking acetylsalicylic acid or NSAIDs including COX-2 (cyclooxygenase-2) inhibitors, experience bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria, or allergic-type reactions.
Pregnancy and lactation (see Use in Pregnancy & Lactation and Pharmacology: Toxicology: Preclinical safety data under Actions).
Severe hepatic dysfunction (serum albumin < 25 g/l or Child-Pugh score ≥ 10).
Estimated renal creatinine clearance < 30 ml/min.
Children and adolescents under 16 years of age.
Inflammatory bowel disease.
Congestive heart failure (NYHA II-IV).
Patients with hypertension whose blood pressure is persistently elevated above 140/90 mmHg and has not been adequately controlled.
Established ischaemic heart disease, peripheral arterial disease and/or cerebrovascular disease.